Objective
To determine if there is evidence of improved clinical outcome during the first 4-6 weeks following treatment with HBO compared with treatment with normobaric oxygen (NBO) for CO poisoning.
Background
Carbon monoxide is an imperceptible gas generated during the incomplete combustion of carbon-based compounds 6 and has an affinity approximately 240 times greater than oxygen for the hemoglobin molecule. Inhaled CO exerts its toxic effect by displacing oxygen and binding to deoxyhemoglobin to form carboxyhemoglobin; by shifting the hemoglobin-oxygen dissociation curve to the left, impairing cellular oxygen delivery; and by interfering with cellular oxygen storage, thus impairing cellular metabolism.
At high concentrations, oxygen competes with CO for hemoglobin binding sites and is therefore a mainstay of therapy for CO poisoning. Carboxyhemoglobin's 4-8-hour half-life falls to approximately 2 hours in the presence of 100% oxygen, and to 30 minutes if 100% oxygen is delivered at 3 atmospheres of pressure. However, despite physiologic rationale supporting the value of HBO therapy, its use in CO poisoning remains controversial and it is typically recommended only for the most severe cases. 8, 9 The objective of this review was to determine if there is evidence that HBO improves clinical outcomes more than NBO in patients being treated for CO poisoning.
Populations studied and study design Table 1 illustrates the settings, population, study designs, interventions, comparison protocol, outcome measures, results, conclusions and limitations of the 6 assessed studies. [1] [2] [3] [4] [5] 7 All studies evaluated non-pregnant adults.
Results
The studies in this analysis used clinical findings, neuropsychological tests, or the electroencephalogram (EEG) to assess the development of neurologic sequelae. Clinically significant neurologic sequelae were detected using physical examination or self-assessment questionnaires. The neuropsychological tests used to identify neurologic sequelae measured attention, information processing, Patients were excluded if they experienced a loss of consciousness -could indicate more severe poisoning. ED = emergency department; HBO = hyperbaric oxygen; ICU = intensive care unit; RCT = randomized controlled trial; O 2 = oxygen; ATA = atmosphere absolute; NBO = refers to 100% oxygen delivered at normobaric pressure unless otherwise specified; CO = carbon monoxide CJEM Journal Club memory, learning, reaction time, temporal-spatial orientation, visual discrimination and visual-spatial functioning. Figure 1 shows key outcomes, stratified by time after exposure. [1] [2] [3] [4] [5] 7 Results that used neuropsychological tests to determine the presence of neurologic sequelae showed no effect over a 12-month course. Results that used clinical findings showed no effect after 6 weeks.
Comments
The Cochrane reviewers, also using 4-6 weeks as the end point for their analysis, were not able to demonstrate unequivocal benefits for HBO therapy and did not recommend it routinely for CO poisoning. In light of this uncertainty, they recommend that a multi-centre trial be performed to define the role, if any, for HBO therapy in CO poisoning. Examination of all the data points drawn from both strategies over a year reveals that although neuropsychological test scores took up to 12 months to return to normal, the self-reporting of symptoms, clinical assessments and activities of daily living had returned to normal after 6 weeks.
All of the published studies to date have numerous limitations that compromise their validity, including lack of blinding, significant loss to follow-up, HBO therapy at below standard treatment levels, difficulty in interpreting reported results, and exclusion of patients with severe CO poisoning. 10 With 14 hospital-based HBO chambers in Canada and over 200 in the United States, most of which are single chamber, accessing a hyperbaric chamber for a patient with CO poisoning can be difficult. Even if available, the limited number of facilities means that most eligible patients would require transportation. Furthermore, HBO therapy has potential risks including decompression sickness, cerebral gas embolism, oxygen toxicity, tympanic membrane rupture, sinus barotrauma and pneumothorax. 
